RedHill Biopharma Ltd. (RDHL)

USD 6.99

(-1.28%)

Total Debt Summary of RedHill Biopharma Ltd.

  • RedHill Biopharma Ltd.'s latest annual total debt in 2023 was 1.17 Million USD , down -99.04% from previous year.
  • RedHill Biopharma Ltd.'s latest quarterly total debt in 2023 FY was 1.17 Million USD , down -99.04% from previous quarter.
  • RedHill Biopharma Ltd. reported annual total debt of 122.69 Million USD in 2022, up 39.72% from previous year.
  • RedHill Biopharma Ltd. reported annual total debt of 87.81 Million USD in 2021, up 1.05% from previous year.
  • RedHill Biopharma Ltd. reported quarterly total debt of 2.28 Million USD for 2023 Q2, down -67.34% from previous quarter.
  • RedHill Biopharma Ltd. reported quarterly total debt of 6.99 Million USD for 2023 Q1, down -94.3% from previous quarter.

Annual Total Debt Chart of RedHill Biopharma Ltd. (2023 - 2011)

Historical Annual Total Debt of RedHill Biopharma Ltd. (2023 - 2011)

Year Total Debt Total Debt Growth
2023 1.17 Million USD -99.04%
2022 122.69 Million USD 39.72%
2021 87.81 Million USD 1.05%
2020 86.9 Million USD 2177.93%
2019 3.81 Million USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%

Peer Total Debt Comparison of RedHill Biopharma Ltd.

Name Total Debt Total Debt Difference
Theratechnologies Inc. 58.96 Million USD 98.011%
Harrow Health, Inc. 190.5 Million USD 99.384%
Dynavax Technologies Corporation 256.91 Million USD 99.543%
Biofrontera Inc. 5.39 Million USD 78.274%
Cronos Group Inc. 2.53 Million USD 53.818%
Sonoma Pharmaceuticals, Inc. 608 Thousand USD -92.929%
Ironwood Pharmaceuticals, Inc. 715.53 Million USD 99.836%
Kala Pharmaceuticals, Inc. 36.32 Million USD 96.771%
Cumberland Pharmaceuticals Inc. 18.42 Million USD 93.635%
Radius Health, Inc. 365.31 Million USD 99.679%
Universe Pharmaceuticals INC 5.48 Million USD 78.604%
DURECT Corporation 20.74 Million USD 94.346%
ProPhase Labs, Inc. 21.38 Million USD 94.514%
Safety Shot Inc 1.54 Million USD 24.272%
Phibro Animal Health Corporation 525.45 Million USD 99.777%
China SXT Pharmaceuticals, Inc. 2.64 Million USD 55.693%
Alvotech 1.07 Billion USD 99.891%
Assertio Holdings, Inc. 40.91 Million USD 97.133%
Supernus Pharmaceuticals, Inc. 41.52 Million USD 97.175%
Rockwell Medical, Inc. 13.43 Million USD 91.272%
Sunshine Biopharma, Inc. 657.7 Thousand USD -78.348%
Procaps Group S.A. 285.93 Million USD 99.59%
Intra-Cellular Therapies, Inc. 16.93 Million USD 93.075%
SCYNEXIS, Inc. 15.08 Million USD 92.221%
Aytu BioPharma, Inc. 15.12 Million USD 92.247%
Viatris Inc. 18.12 Billion USD 99.994%
OptiNose, Inc. 131.74 Million USD 99.11%
SIGA Technologies, Inc. 1.46 Million USD 19.877%
Tilray Brands, Inc. 387.31 Million USD 99.697%
PetIQ, Inc. 468.3 Million USD 99.75%
Sunshine Biopharma, Inc. 657.7 Thousand USD -78.348%
Neurocrine Biosciences, Inc. 428.4 Million USD 99.726%
Guardion Health Sciences, Inc. - USD -Infinity%
Alimera Sciences, Inc. 67.39 Million USD 98.26%
Collegium Pharmaceutical, Inc. 674.28 Million USD 99.826%
Silver Spike Investment Corp. - USD -Infinity%
Shuttle Pharmaceuticals Holdings, Inc. 1.08 Million USD -7.843%
Organogenesis Holdings Inc. 119.35 Million USD 99.017%
Journey Medical Corporation 17.73 Million USD 93.384%
Petros Pharmaceuticals, Inc. 8.27 Million USD 85.827%
Alpha Teknova, Inc. 30.45 Million USD 96.149%
Clever Leaves Holdings Inc. 2.08 Million USD 43.795%
Lifecore Biomedical, Inc. 130.36 Million USD 99.1%
PainReform Ltd. 86 Thousand USD -1263.96%
Cosmos Health Inc. 12.42 Million USD 90.559%
Avadel Pharmaceuticals plc 35.38 Million USD 96.685%
TherapeuticsMD, Inc. 8 Million USD 85.347%
Embecta Corp. 1.63 Billion USD 99.928%
Regencell Bioscience Holdings Limited 59.8 Thousand USD -1861.319%
Talphera, Inc. - USD -Infinity%
Pacira BioSciences, Inc. 586.04 Million USD 99.8%
Incannex Healthcare Limited 373 Thousand USD -214.479%
Cyclo Therapeutics, Inc. 1.03 Million USD -13.541%
Shineco, Inc. 29.65 Million USD 96.045%
Procaps Group, S.A. 285.93 Million USD 99.59%
ANI Pharmaceuticals, Inc. 315.32 Million USD 99.628%
Aquestive Therapeutics, Inc. 98.82 Million USD 98.813%
Lantheus Holdings, Inc. 616.94 Million USD 99.81%
Alvotech 1.07 Billion USD 99.891%
Hempacco Co., Inc. 13.72 Million USD 91.453%
Eagle Pharmaceuticals, Inc. 62.46 Million USD 98.122%
Bright Green Corporation 1.85 Million USD 36.655%
Esperion Therapeutics, Inc. 540.94 Million USD 99.783%
Kamada Ltd. 8.74 Million USD 86.593%
Indivior PLC 281.6 Million USD 99.583%
Evoke Pharma, Inc. 5 Million USD 76.54%
Flora Growth Corp. 3.67 Million USD 68.055%
Cyclo Therapeutics, Inc. 1.03 Million USD -13.541%
Evolus, Inc. 126.54 Million USD 99.073%
HUTCHMED (China) Limited 86.13 Million USD 98.638%
Amphastar Pharmaceuticals, Inc. 623.64 Million USD 99.812%
Akanda Corp. 3.99 Million USD 70.666%